139 related articles for article (PubMed ID: 36798226)
21. Identification of the minimal active soluble TREM2 sequence for modulating microglial phenotypes and amyloid pathology.
Sheng X; Yao Y; Huang R; Xu Y; Zhu Y; Chen L; Zhang L; Wang W; Zhuo R; Can D; Chang CF; Zhang YW; Xu H; Bu G; Zhong L; Chen XF
J Neuroinflammation; 2021 Dec; 18(1):286. PubMed ID: 34893068
[TBL] [Abstract][Full Text] [Related]
22. Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms.
Takatori S; Wang W; Iguchi A; Tomita T
Adv Exp Med Biol; 2019; 1118():83-116. PubMed ID: 30747419
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response.
Pimenova AA; Herbinet M; Gupta I; Machlovi SI; Bowles KR; Marcora E; Goate AM
Neurobiol Dis; 2021 Jan; 148():105217. PubMed ID: 33301878
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease.
Gao C; Shen X; Tan Y; Chen S
J Neuroinflammation; 2022 Sep; 19(1):215. PubMed ID: 36058959
[TBL] [Abstract][Full Text] [Related]
25. Functional BRI2-TREM2 interactions in microglia: implications for Alzheimer's and related dementias.
Yin T; Yesiltepe M; D'Adamio L
EMBO Rep; 2024 Mar; 25(3):1326-1360. PubMed ID: 38347225
[TBL] [Abstract][Full Text] [Related]
26. Microglial amyloid beta clearance is driven by PIEZO1 channels.
Jäntti H; Sitnikova V; Ishchenko Y; Shakirzyanova A; Giudice L; Ugidos IF; Gómez-Budia M; Korvenlaita N; Ohtonen S; Belaya I; Fazaludeen F; Mikhailov N; Gotkiewicz M; Ketola K; Lehtonen Š; Koistinaho J; Kanninen KM; Hernández D; Pébay A; Giugno R; Korhonen P; Giniatullin R; Malm T
J Neuroinflammation; 2022 Jun; 19(1):147. PubMed ID: 35706029
[TBL] [Abstract][Full Text] [Related]
27. Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer's disease, providing new insights into its disease mechanisms.
Wang Z; Zhang Q; Lin JR; Jabalameli MR; Mitra J; Nguyen N; Zhang ZD
Sci Rep; 2021 Oct; 11(1):20511. PubMed ID: 34654853
[TBL] [Abstract][Full Text] [Related]
28. Complement receptor 1 is expressed on brain cells and in the human brain.
Daskoulidou N; Shaw B; Torvell M; Watkins L; Cope EL; Carpanini SM; Allen ND; Morgan BP
Glia; 2023 Jun; 71(6):1522-1535. PubMed ID: 36825534
[TBL] [Abstract][Full Text] [Related]
29. Shared genes between Alzheimer's disease and ischemic stroke.
Wei CJ; Cui P; Li H; Lang WJ; Liu GY; Ma XF
CNS Neurosci Ther; 2019 Aug; 25(8):855-864. PubMed ID: 30859738
[TBL] [Abstract][Full Text] [Related]
30. The FcεRIβ homologue, MS4A4A, promotes FcεRI signal transduction and store-operated Ca
Arthur GK; Ehrhardt-Humbert LC; Snider DB; Jania C; Tilley SL; Metcalfe DD; Cruse G
Cell Signal; 2020 Jul; 71():109617. PubMed ID: 32240745
[TBL] [Abstract][Full Text] [Related]
31. Neuroinflammation in Alzheimer's disease: microglial signature and their relevance to disease.
Sobue A; Komine O; Yamanaka K
Inflamm Regen; 2023 May; 43(1):26. PubMed ID: 37165437
[TBL] [Abstract][Full Text] [Related]
32. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease.
Claes C; Danhash EP; Hasselmann J; Chadarevian JP; Shabestari SK; England WE; Lim TE; Hidalgo JLS; Spitale RC; Davtyan H; Blurton-Jones M
Mol Neurodegener; 2021 Jul; 16(1):50. PubMed ID: 34301296
[TBL] [Abstract][Full Text] [Related]
33. A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer's disease patients from controls.
Pesämaa I; Müller SA; Robinson S; Darcher A; Paquet D; Zetterberg H; Lichtenthaler SF; Haass C
Mol Neurodegener; 2023 Sep; 18(1):70. PubMed ID: 37775827
[TBL] [Abstract][Full Text] [Related]
34. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide association study identifies Alzheimer's risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels.
Hou XH; Bi YL; Tan MS; Xu W; Li JQ; Shen XN; Dou KX; Tan CC; Tan L; ; Yu JT
Neurobiol Aging; 2019 Dec; 84():241.e13-241.e20. PubMed ID: 31204042
[TBL] [Abstract][Full Text] [Related]
37. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
[TBL] [Abstract][Full Text] [Related]
38. A Trisomy 21-linked Hematopoietic Gene Variant in Microglia Confers Resilience in Human iPSC Models of Alzheimer's Disease.
Jin M; Ma Z; Dang R; Zhang H; Kim R; Xue H; Pascual J; Finkbeiner S; Head E; Liu Y; Jiang P
bioRxiv; 2024 Mar; ():. PubMed ID: 38559257
[TBL] [Abstract][Full Text] [Related]
39. Microglia and its Genetics in Alzheimer's Disease.
Liang X; Wu H; Colt M; Guo X; Pluimer B; Zeng J; Dong S; Zhao Z
Curr Alzheimer Res; 2021; 18(9):676-688. PubMed ID: 34749609
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures.
Sakae N; Heckman MG; Vargas ER; Carrasquillo MM; Murray ME; Kasanuki K; Ertekin-Taner N; Younkin SG; Dickson DW
J Alzheimers Dis; 2019; 70(3):659-666. PubMed ID: 31256143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
